GlassScriptPhysician profile
Allison H Phillips
NPI 1295866374
$2,427.35
in general payments reported to CMS, 2019-2025
32 companies · $520 in 2025
The $520 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $66.99 · 2021: $287 · 2022: $458 · 2023: $482 · 2024: $175 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.77 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $432.25 | 2019-2025 | Veozah |
| Abbvie INC. | $334.68 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $268.70 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $210.42 | 2022-2025 | |
| Exeltis, USA INC. | $147.58 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $132.64 | 2021-2024 | Omni Hysteroscope, Acessa Provu System, Coolseal Generator |
| Coopersurgical, INC. | $93.30 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Daiichi Sankyo INC. | $83.77 | 2019-2023 | Injectafer |
| Allergan, INC. | $81.63 | 2019-2020 | |
| Organon LLC | $63.03 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $55.78 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $50.00 | 2019-2022 | |
| Karl Storz Endoscopy-America | $46.90 | 2019-2020 | |
| Therapeuticsmd, INC. | $46.51 | 2019-2022 | |
| Amgen INC. | $43.28 | 2022-2023 | Prolia, Evenity |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $28.44 | 2019 | |
| Avion Pharmaceuticals | $27.84 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $27.67 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.73 | 2019 | |
| Pfizer INC. | $25.10 | 2021-2022 | |
| Octapharma USA, INC. | $23.52 | 2025 | Fibryga |
| Asensus Surgical, INC. | $21.46 | 2019 | |
| Baxter Healthcare | $19.68 | 2023 | Floseal |
| Sumitomo Pharma America, INC. | $19.38 | 2024 | Myfembree |
| Myovant Sciences INC. | $19.26 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.94 | 2020 | |
| Olympus America INC. | $15.24 | 2023 | Olympus |
| Mallinckrodt Enterprises LLC | $13.50 | 2019 | |
| Boston Scientific Corporation | $13.44 | 2022 | |
| Exact Sciences Corporation | $13.30 | 2023 | Cologuard Collection Kit |
| Meditrina | $12.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.